Cleveland Clinic will host its annual Head & Neck Alumni Day on November 22, 2024, at the Lerner Research Institute, focusing on recent clinical trial advancements in head and neck cancer. The event aims to update clinicians and surgeons on contemporary management strategies and the importance of a multidisciplinary approach.
The symposium will feature lectures and panel discussions covering updated therapies and new treatment innovations. Natalie Silver, MD, MS, will moderate a discussion on the "Latest and Greatest Clinical Trials in Curative Mucosal Squamous Cell Cancer." Jamie Ku, MD, will lead a discussion on "Key Impactful Clinical Trials in the Recurrent/Metastatic Setting." Brandon Prendes, MD, will moderate a panel on "Recent Innovative Trials in the Non-mucosal Head and Neck Malignancies."
The panels will include head and neck surgeons, otolaryngologists, and oncologists from Cleveland Clinic, along with guest speakers from institutions such as the University of Texas MD Anderson Cancer Center, Medical University of South Carolina, Oregon Health & Science University, and Henry Ford Health.
Key Takeaways for Attendees
Attendees can expect to enhance their understanding of several critical areas:
- The importance of a multidisciplinary approach in treating head and neck cancer.
- Modern surgical technique updates.
- Modern radiation and chemotherapy strategy updates.
- Recognition and diagnosis of rare head and neck cancer diagnoses.
- Management of appropriate referral decisions.
The course is designed for head and neck surgeons, otolaryngologists, medical oncologists, radiation oncologists, trainees, Advanced Practice Providers, speech-language pathologists, and nurses involved in diagnosing and treating head and neck cancer patients.
Registration details are available on the Cleveland Clinic website, with a deadline of November 18, 2024. The activity has been approved for AMA PRA Category 1 Credit™.
